{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:03:20Z","timestamp":1773086600901,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T00:00:00Z","timestamp":1348099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T00:00:00Z","timestamp":1348099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                        <jats:title>Introduction\n<\/jats:title>\n                        <jats:p>Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been shown to be important in the development of inflammatory models of rheumatoid arthritis and there is encouraging data that its blockade may have clinical relevance in patients with rheumatoid arthritis. The aims of the current study were to determine whether GM-CSF may also be important for disease and pain development in a model of osteoarthritis.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods\n<\/jats:title>\n                        <jats:p>The role of GM-CSF was investigated using the collagenase-induced instability model of osteoarthritis. We studied both GM-CSF-\/- mice and wild-type (C57BL\/6) mice treated prophylactically or therapeutically with a monoclonal antibody to GM-CSF. Disease development (both early and late) was evaluated by histology and knee pain development was measured by assessment of weight distribution.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results\n<\/jats:title>\n                        <jats:p>In the absence of GM-CSF, there was less synovitis and matrix metalloproteinase-mediated neoepitope expression at week 2 post disease induction, and less cartilage damage at week 6. GM-CSF was absolutely required for pain development. Therapeutic neutralization of GM-CSF not only abolished the pain within 3 days but also led to significantly reduced cartilage damage.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions\n<\/jats:title>\n                        <jats:p>GM-CSF is key to the development of experimental osteoarthritis and its associated pain. Importantly, GM-CSF neutralization by a therapeutic monoclonal antibody-based protocol rapidly and completely abolished existing arthritic pain and suppressed the degree of arthritis development. Our results suggest that it would be worth exploring the importance of GM-CSF for pain and disease in other osteoarthritis models and perhaps clinically for this form of arthritis.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar4037","type":"journal-article","created":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T12:14:20Z","timestamp":1348143260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development"],"prefix":"10.1186","volume":"14","author":[{"given":"Andrew D","family":"Cook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarrad","family":"Pobjoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Steidl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"D\u00fcrr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma L","family":"Braine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda L","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek C","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,20]]},"reference":[{"key":"3756_CR1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/blood.V56.6.947.947","volume":"56","author":"AW Burgess","year":"1980","unstructured":"Burgess AW, Metcalf D: The nature and action of granulocyte-macrophage colony stimulating factors. Blood. 1980, 56: 947-958.","journal-title":"Blood"},{"key":"3756_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nri2356","volume":"8","author":"JA Hamilton","year":"2008","unstructured":"Hamilton JA: Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol. 2008, 8: 533-544. 10.1038\/nri2356.","journal-title":"Nat Rev Immunol"},{"key":"3756_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/jcp.1041030309","volume":"103","author":"JA Hamilton","year":"1980","unstructured":"Hamilton JA, Stanley ER, Burgess AW, Shadduck RK: Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol. 1980, 103: 435-445. 10.1002\/jcp.1041030309.","journal-title":"J Cell Physiol"},{"key":"3756_CR4","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/0140-6736(93)91653-4","volume":"342","author":"JA Hamilton","year":"1993","unstructured":"Hamilton JA: Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs. Lancet. 1993, 342: 536-539. 10.1016\/0140-6736(93)91653-4.","journal-title":"Lancet"},{"key":"3756_CR5","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.4049\/jimmunol.178.8.5245","volume":"178","author":"AJ Fleetwood","year":"2007","unstructured":"Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD: Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol. 2007, 178: 5245-5252.","journal-title":"J Immunol"},{"key":"3756_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ni1340","volume":"7","author":"SH Naik","year":"2006","unstructured":"Naik SH, Metcalf D, van Nieuwenhuijze A, Wicks I, Wu L, O'Keeffe M, Shortman K: Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol. 2006, 7: 663-671.","journal-title":"Nat Immunol"},{"key":"3756_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/ar318","volume":"3","author":"AD Cook","year":"2001","unstructured":"Cook AD, Braine EL, Campbell IK, Rich MJ, Hamilton JA: Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 2001, 3: 293-298. 10.1186\/ar318.","journal-title":"Arthritis Res"},{"key":"3756_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/1529-0131(200101)44:1<111::AID-ANR15>3.0.CO;2-1","volume":"44","author":"YH Yang","year":"2001","unstructured":"Yang YH, Hamilton JA: Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor. Arthritis Rheum. 2001, 44: 111-119. 10.1002\/1529-0131(200101)44:1<111::AID-ANR15>3.0.CO;2-1.","journal-title":"Arthritis Rheum"},{"key":"3756_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/ard.2007.085431","volume":"68","author":"C Plater-Zyberk","year":"2009","unstructured":"Plater-Zyberk C, Joosten LA, Helsen MM, Koenders MI, Baeuerle PA, van den Berg WB: Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model. Ann Rheum Dis. 2009, 68: 721-728. 10.1136\/ard.2007.085431.","journal-title":"Ann Rheum Dis"},{"key":"3756_CR10","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1002\/art.30354","volume":"63","author":"AD Cook","year":"2011","unstructured":"Cook AD, Turner AL, Braine EL, Pobjoy J, Lenzo JC, Hamilton JA: Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis. Arthritis Rheum. 2011, 63: 2340-2351. 10.1002\/art.30354.","journal-title":"Arthritis Rheum"},{"key":"3756_CR11","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1136\/ard.2010.146225","volume":"70","author":"GR Burmester","year":"2011","unstructured":"Burmester GR, Feist E, Sleeman MA, Wang B, White B, Magrini F: Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-alpha, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study. Ann Rheum Dis. 2011, 70: 1542-1549. 10.1136\/ard.2010.146225.","journal-title":"Ann Rheum Dis"},{"key":"3756_CR12","first-page":"4044","volume":"63","author":"GR Burmester","year":"2011","unstructured":"Burmester GR, Weinblatt ME, Barbarash O, Vatutin M, Szombati I, Stoilov R, Matsievskaya G, Venalis A, Esfandiari E, Grove G, Saurigny D, Sleeman MA, Godwood A, Magrini F: Mavrilimumab (an anti-GM-CSFR\u03b1 monoclonal antibody) in subjects with rheumatoid arthritis: results of a phase 2 randomized, double-blind, placebo-controlled study [abstract]. Arthritis Rheum. 2011, 63: 4044-","journal-title":"Arthritis Rheum"},{"key":"3756_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/BF03327357","volume":"15","author":"F Iannone","year":"2003","unstructured":"Iannone F, Lapadula G: The pathophysiology of osteoarthritis. Aging Clin Exp Res. 2003, 15: 364-372.","journal-title":"Aging Clin Exp Res"},{"key":"3756_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/art.1780400419","volume":"40","author":"TD Spector","year":"1997","unstructured":"Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, Pepys MB: Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum. 1997, 40: 723-727. 10.1002\/art.1780400419.","journal-title":"Arthritis Rheum"},{"key":"3756_CR15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1053\/joca.2002.0800","volume":"10","author":"M Sowers","year":"2002","unstructured":"Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L: C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage. 2002, 10: 595-601. 10.1053\/joca.2002.0800.","journal-title":"Osteoarthritis Cartilage"},{"key":"3756_CR16","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/art.11094","volume":"48","author":"L Haywood","year":"2003","unstructured":"Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, Walsh DA: Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum. 2003, 48: 2173-2177. 10.1002\/art.11094.","journal-title":"Arthritis Rheum"},{"key":"3756_CR17","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/ard.52.12.870","volume":"52","author":"MN Farahat","year":"1993","unstructured":"Farahat MN, Yanni G, Poston R, Panayi GS: Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis. 1993, 52: 870-875. 10.1136\/ard.52.12.870.","journal-title":"Ann Rheum Dis"},{"key":"3756_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/art.27290","volume":"62","author":"J Bondeson","year":"2010","unstructured":"Bondeson J, Blom AB, Wainwright S, Hughes C, Caterson B, van den Berg WB: The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum. 2010, 62: 647-657.","journal-title":"Arthritis Rheum"},{"key":"3756_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/art.1780340205","volume":"34","author":"B Haraoui","year":"1991","unstructured":"Haraoui B, Pelletier JP, Cloutier JM, Faure MP, Martel-Pelletier J: Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs. Arthritis Rheum. 1991, 34: 153-163. 10.1002\/art.1780340205.","journal-title":"Arthritis Rheum"},{"key":"3756_CR20","first-page":"1001","volume":"135","author":"PM van der Kraan","year":"1989","unstructured":"van der Kraan PM, Vitters EL, van de Putte LB, van den Berg WB: Development of osteoarthritic lesions in mice by \"metabolic\" and \"mechanical\" alterations in the knee joints. Am J Pathol. 1989, 135: 1001-1014.","journal-title":"Am J Pathol"},{"key":"3756_CR21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.joca.2004.03.003","volume":"12","author":"AB Blom","year":"2004","unstructured":"Blom AB, van Lent PL, Holthuysen AE, van der Kraan PM, Roth J, van Rooijen N, van den Berg WB: Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage. 2004, 12: 627-635. 10.1016\/j.joca.2004.03.003.","journal-title":"Osteoarthritis Cartilage"},{"key":"3756_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/art.24247","volume":"60","author":"AB Blom","year":"2009","unstructured":"Blom AB, Brockbank SM, van Lent PL, van Beuningen HM, Geurts J, Takahashi N, van der Kraan PM, van de Loo FA, Schreurs BW, Clements K, Newham P, van den Berg WB: Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum. 2009, 60: 501-512. 10.1002\/art.24247.","journal-title":"Arthritis Rheum"},{"key":"3756_CR23","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1093\/rheumatology\/ker283","volume":"50","author":"N Sofat","year":"2011","unstructured":"Sofat N, Ejindu V, Kiely P: What makes osteoarthritis painful? The evidence for local and central pain processing. Rheumatology (Oxford). 2011, 50: 2157-2165. 10.1093\/rheumatology\/ker283.","journal-title":"Rheumatology (Oxford)"},{"key":"3756_CR24","volume-title":"Ann Rheum Dis","author":"AD Cook","year":"2012","unstructured":"Cook AD, Pobjoy J, Sarros S, Steidl S, Durr M, Lacey DC, Hamilton JA: Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain. Ann Rheum Dis. 2012."},{"key":"3756_CR25","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1073\/pnas.91.12.5592","volume":"91","author":"E Stanley","year":"1994","unstructured":"Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, Maher DW, Cebon J, Sinickas V, Dunn AR: Granulocyte\/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA. 1994, 91: 5592-5596. 10.1073\/pnas.91.12.5592.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3756_CR26","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.4049\/jimmunol.161.7.3639","volume":"161","author":"IK Campbell","year":"1998","unstructured":"Campbell IK, Rich MJ, Bischof RJ, Dunn AR, Grail D, Hamilton JA: Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J Immunol. 1998, 161: 3639-3644.","journal-title":"J Immunol"},{"key":"3756_CR27","first-page":"19","volume":"71","author":"PM van der Kraan","year":"1990","unstructured":"van der Kraan PM, Vitters EL, van Beuningen HM, van de Putte LB, van den Berg WB: Degenerative knee joint lesions in mice after a single intra-articular collagenase injection. A new model of osteoarthritis. J Exp Pathol (Oxford). 1990, 71: 19-31.","journal-title":"J Exp Pathol (Oxford)"},{"key":"3756_CR28","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1002\/art.23870","volume":"58","author":"JJ Inglis","year":"2008","unstructured":"Inglis JJ, McNamee KE, Chia SL, Essex D, Feldmann M, Williams RO, Hunt SP, Vincent T: Regulation of pain sensitivity in experimental osteoarthritis by the endogenous peripheral opioid system. Arthritis Rheum. 2008, 58: 3110-3119. 10.1002\/art.23870.","journal-title":"Arthritis Rheum"},{"key":"3756_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.brainresrev.2008.12.012","volume":"60","author":"SE Bove","year":"2009","unstructured":"Bove SE, Flatters SJ, Inglis JJ, Mantyh PW: New advances in musculoskeletal pain. Brain Res Rev. 2009, 60: 187-201. 10.1016\/j.brainresrev.2008.12.012.","journal-title":"Brain Res Rev"},{"key":"3756_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/ard.2006.057182","volume":"66","author":"C Plater-Zyberk","year":"2007","unstructured":"Plater-Zyberk C, Joosten LA, Helsen MM, Hepp J, Baeuerle PA, van den Berg WB: GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice. Ann Rheum Dis. 2007, 66: 452-457.","journal-title":"Ann Rheum Dis"},{"key":"3756_CR31","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/art.34315","volume":"64","author":"PL van Lent","year":"2012","unstructured":"van Lent PL, Blom AB, Schelbergen RF, Sloetjes A, Lafeber FP, Lems WF, Cats H, Vogl T, Roth J, van den Berg WB: Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum. 2012, 64: 1466-1476. 10.1002\/art.34315.","journal-title":"Arthritis Rheum"},{"key":"3756_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","volume":"14","author":"KP Pritzker","year":"2006","unstructured":"Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB: Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2006, 14: 13-29. 10.1016\/j.joca.2005.07.014.","journal-title":"Osteoarthritis Cartilage"},{"key":"3756_CR33","doi-asserted-by":"publisher","first-page":"R199","DOI":"10.1186\/ar3171","volume":"12","author":"CM De Nardo","year":"2010","unstructured":"De Nardo CM, Lenzo JC, Pobjoy J, Hamilton JA, Cook AD: Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models. Arthritis Res Ther. 2010, 12: R199-10.1186\/ar3171.","journal-title":"Arthritis Res Ther"},{"key":"3756_CR34","doi-asserted-by":"publisher","first-page":"33038","DOI":"10.1074\/jbc.275.42.33038","volume":"275","author":"FA Mercuri","year":"2000","unstructured":"Mercuri FA, Maciewicz RA, Tart J, Last K, Fosang AJ: Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity. J Biol Chem. 2000, 275: 33038-33045.","journal-title":"J Biol Chem"},{"key":"3756_CR35","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/1529-0131(199906)42:6<1128::AID-ANR9>3.0.CO;2-2","volume":"42","author":"JB van Meurs","year":"1999","unstructured":"van Meurs JB, van Lent PL, Holthuysen AE, Bayne EK, van den Berg WB: Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis. Arthritis Rheum. 1999, 42: 1128-1139. 10.1002\/1529-0131(199906)42:6<1128::AID-ANR9>3.0.CO;2-2.","journal-title":"Arthritis Rheum"},{"issue":"Pt 3","key":"3756_CR36","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1042\/bj3050799","volume":"305","author":"CE Hughes","year":"1995","unstructured":"Hughes CE, Caterson B, Fosang AJ, Roughley PJ, Mort JS: Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem J. 1995, 305 (Pt 3): 799-804.","journal-title":"Biochem J"},{"key":"3756_CR37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","volume":"6","author":"J Sellam","year":"2010","unstructured":"Sellam J, Berenbaum F: The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010, 6: 625-635. 10.1038\/nrrheum.2010.159.","journal-title":"Nat Rev Rheumatol"},{"key":"3756_CR38","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/art.24505","volume":"60","author":"JA Hamilton","year":"2009","unstructured":"Hamilton JA, Tak PP: The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum. 2009, 60: 1210-1221. 10.1002\/art.24505.","journal-title":"Arthritis Rheum"},{"key":"3756_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/rheumatology\/keh411","volume":"44","author":"DT Felson","year":"2005","unstructured":"Felson DT, Gale DR, Elon Gale M, Niu J, Hunter DJ, Goggins J, Lavalley MP: Osteophytes and progression of knee osteoarthritis. Rheumatology (Oxford). 2005, 44: 100-104. 10.1093\/rheumatology\/keh411.","journal-title":"Rheumatology (Oxford)"},{"key":"3756_CR40","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1136\/ard.2010.147553","volume":"70","author":"MC Kortekaas","year":"2011","unstructured":"Kortekaas MC, Kwok WY, Reijnierse M, Huizinga TW, Kloppenburg M: Osteophytes and joint space narrowing are independently associated with pain in finger joints in hand osteoarthritis. Ann Rheum Dis. 2011, 70: 1835-1837. 10.1136\/ard.2010.147553.","journal-title":"Ann Rheum Dis"},{"key":"3756_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF02003233","volume":"31","author":"LA Joosten","year":"1990","unstructured":"Joosten LA, Helsen MM, van den Berg WB: Protective effect of rimexolone on cartilage damage in arthritic mice: a comparative study with triamcinolone hexacetonide. Agents Actions. 1990, 31: 135-142. 10.1007\/BF02003233.","journal-title":"Agents Actions"},{"key":"3756_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/art.11422","volume":"50","author":"PL van Lent","year":"2004","unstructured":"van Lent PL, Blom AB, van der Kraan P, Holthuysen AE, Vitters E, van Rooijen N, Smeets RL, Nabbe KC, van den Berg WB: Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum. 2004, 50: 103-111. 10.1002\/art.11422.","journal-title":"Arthritis Rheum"},{"key":"3756_CR43","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nm.1976","volume":"15","author":"M Schweizerhof","year":"2009","unstructured":"Schweizerhof M, Stosser S, Kurejova M, Njoo C, Gangadharan V, Agarwal N, Schmelz M, Bali KK, Michalski CW, Brugger S, Dickenson A, Simone DA, Kuner R: Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain. Nat Med. 2009, 15: 802-807. 10.1038\/nm.1976.","journal-title":"Nat Med"},{"key":"3756_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/138945007779940179","volume":"8","author":"AB Blom","year":"2007","unstructured":"Blom AB, van der Kraan PM, van den Berg WB: Cytokine targeting in osteoarthritis. Curr Drug Targets. 2007, 8: 283-292. 10.2174\/138945007779940179.","journal-title":"Curr Drug Targets"},{"key":"3756_CR45","first-page":"29","volume-title":"Haemopoietic Growth Factors and Mononuclear Phagocytes","author":"JA Hamilton","year":"1993","unstructured":"Hamilton JA: A colony-stimulating factor network involving mononuclear phagocytes and other cells. Haemopoietic Growth Factors and Mononuclear Phagocytes. Edited by: van Furth R. 1993, Basel: Karger, 29-35."},{"key":"3756_CR46","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/1529-0131(199804)41:4<647::AID-ART11>3.0.CO;2-T","volume":"41","author":"JB van Meurs","year":"1998","unstructured":"van Meurs JB, van Lent PL, Bayne EK, van de Loo FA, van den Berg WB: Interleukin-1 receptor antagonist prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen-induced arthritis. Arthritis Rheum. 1998, 41: 647-656. 10.1002\/1529-0131(199804)41:4<647::AID-ART11>3.0.CO;2-T.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar4037\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:44:54Z","timestamp":1728384294000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar4037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,20]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,10]]}},"alternative-id":["3756"],"URL":"https:\/\/doi.org\/10.1186\/ar4037","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,20]]},"assertion":[{"value":"27 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R199"}}